Teva Pharmaceutical Industries Limited revenue breakdown overview

Teva Pharmaceutical Industries Limited revenue for the last year amounted to 16.54 B USD, the most of which — 16.54 B USD — came from its highest performing source at the moment, Generics, Innovative Medicines and Biopharmaceuticals, the year earlier bringing 15.85 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Teva Pharmaceutical Industries Limited 8.03 B USD, and the year before that — 8.12 B USD.